Cambridge Nutritional Sciences plc (AIM:CNSL)
London · Delayed Price · Currency is GBP · Price in GBX 1.827
-0.073 (-3.86%)
May 29, 2026, 12:01 PM GMT
AIM:CNSL Market Cap
AIM:CNSL has a market cap or net worth of 4.52 million as of May 29, 2026. Its market cap has decreased by -25.49% in one year.
Market Cap
4.52M
Enterprise Value
1.16M
Revenue
8.06M
Ranking
n/a
PE Ratio
3.31
Stock Price
1.83
Market Cap Chart
Since December 7, 2007, AIM:CNSL's market cap has increased from 3.12M to 4.52M, an increase of 44.73%. That is a compound annual growth rate of 2.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 4.52M | -2.56% |
| Dec 31, 2025 | 4.64M | -29.09% |
| Dec 31, 2024 | 6.54M | 14.71% |
| Dec 29, 2023 | 5.70M | -36.00% |
| Dec 30, 2022 | 8.91M | -82.10% |
| Dec 31, 2021 | 49.78M | -57.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.04B |
| GSK plc | 76.57B |
| Haleon | 30.27B |
| Smith & Nephew | 9.49B |
| CRISM Therapeutics | 5.69M |
| Thalia Therapeutics | 5.41M |
| Theracryf | 4.94M |
| Surgical Innovations Group | 4.43M |